Immunological biomarkers: Catalysts for translational advances in autoimmune diabetes-Reference-Cited by-同舟云学术

Immunological biomarkers: Catalysts for translational advances in autoimmune diabetes

Published:2013-04-10 Issue:2 Volume:172 Page:178-185
ISSN:1365-2249
Container-title:Clinical and Experimental Immunology
language:en
Short-container-title:

Author:

Ahmed S T¹,Akirav E²,Bradshaw E³,Buckner J⁴,McKinney E⁵,Quintana F J³,Waldron-Lynch F⁵,Nepom J⁴

Affiliation:

1. JDRF, New York, NY

2. Research Institute, Winthrop University Hospital, New York, NY

3. Center for Neurologic Diseases, Harvard Medical School, Boston, MA

4. Benaroya Research Institute, Virginia Mason University, Seattle, WA, USA

5. Department of Translational Medicine, Cambridge Institute for Medical Research, Cambridge, UK

Abstract

Summary In a recent workshop organized by the JDRF focused on the ‘Identification and Utilization of Robust Biomarkers in Type1 Diabetes’, leaders in the field of type 1 diabetes (T1D)/autoimmunity and assay technology came together from academia, government and industry to assess the current state of the field, evaluate available resources/technologies and identify gaps that need to be filled for moving the field of T1D research forward. The highlights of this workshop are discussed in this paper, as well as the proposal for a larger, planned consortium effort, incorporating a JDRF Biomarker Core, to foster collaboration and accelerate progress in this critically needed area of T1D research.

Publisher

Oxford University Press (OUP)

Subject

Immunology,Immunology and Allergy

Link

https://academic.oup.com/cei/article-pdf/172/2/178/41788472/cei12063.pdf

Reference40 articles.

1. Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes.;Roep;Nat Rev Immunol,2010

2. Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologies;Carey;Expert Opin Med Diagn,2010

3. The problems and promises of research into human immunology and autoimmune disease;Roep;Nat Med,2012

4. Type 1 diabetes: etiology, immunology, and therapeutic strategies;van Belle;Physiol Rev,2011

5. Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients;Gaglia;J Clin Invest,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D);Trials;2015-03-11

2. Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation;Biomarker Insights;2015-01

3. Progress in immune-based therapies for type 1 diabetes;Clinical and Experimental Immunology;2013-04-10